Extensive safety testing and manufacturing improvements have now made it possible to bring the drug back to the US market.

FDA clears reformulated ranitidine after five years, ensuring safety with new labeling and storage instructions for acid-reducing treatment.

The U.S. Food and Drug Administration announced Wednesday it is requesting manufacturers remove all prescription and over-the-counter ranitidine drugs from the market immediately. This is the latest ...